- Home
- AAL vs RGC Comparison
AAL vs RGC Comparison
Compare AAL & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAL | RGC |
|---|---|---|
| Founded | 1930 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 8.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AAL | RGC |
|---|---|---|
| Price | $14.99 | $17.23 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $15.21 | N/A |
| AVG Volume (30 Days) | ★ 54.0M | 210.3K |
| Earning Date | 01-22-2026 | 10-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 115.68 | N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $54,294,000,000.00 | N/A |
| Revenue This Year | $2.20 | N/A |
| Revenue Next Year | $6.29 | N/A |
| P/E Ratio | $16.55 | ★ N/A |
| Revenue Growth | ★ 1.27 | N/A |
| 52 Week Low | $8.50 | $0.09 |
| 52 Week High | $19.10 | $83.60 |
Technical Indicators
Market Signals| Indicator | AAL | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 66.75 | 64.34 |
| Support Level | $14.70 | $16.10 |
| Resistance Level | $15.35 | $17.40 |
| Average True Range (ATR) | 0.49 | 1.62 |
| MACD | 0.10 | 0.63 |
| Stochastic Oscillator | 85.66 | 88.24 |
Price Performance
Historical ComparisonAbout AAL American Airlines Group Inc.
American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest fleet of US legacy carriers.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.